BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 16, 2006
View Archived Issues
Nalmefene shows promise in treating pathological gambling / News in Context
Read More
NXY-059 appears to reduce disability in ischemic stroke patients
Read More
LRH-1 activation: Potential efficacy as a treatment for atherosclerosis
Read More
New localized radiotherapeutic for prostate cancer
Read More
Capsaicin patch reduces pain in HIV-associated distal sensory polyneuropathy
Read More
GCPII inhibitor targeted for neuroprotection and prostate cancer
Read More
Neurochem completes rolling NDA for Fibrillex in AA amyloidosis
Read More
Phase I study of lemuteporfin in BPH fails to meet primary efficacy objective
Read More
Santen updates status of ophthalmic programs
Read More
ProMetic BioSciences cleared for Canadian phase Ib/II study of PBI-1402
Read More
Ranbaxy and CIH establish joint venture for antiretrovirals in South Africa
Read More
Eltrombopag begins phase III trials for ITP
Read More
Avant's typhoid fever vaccine Ty-800 studied in new phase I/II trial
Read More
BioXell and Lay Line Genomics sign agreement for MNAC13
Read More
European COMP recommends orphan drug designation for 1D09C3
Read More
Orthokine approved in E.U.
Read More
Glenmark discovers new drug targeting obesity
Read More
Retapamulin NDA under FDA review
Read More
Pfizer looks to value drivers to grow business
Read More
Prophylactic and therapeutic efficacy of targeting TLR9 for HSV-2
Read More
Recent Incyte patent describes new therapeutic agents for HIV infection
Read More
New agents for endocrine-related disorders imparted in recent patent literature
Read More
Orphan drug designation for TRX-4 in type 1 diabetes
Read More
Phase Ib trial investigates AP-23573 plus doxorubicin for cancer
Read More
MB-07803 studied in phase I for type 2 diabetes
Read More
New therapeutic agents described for cardiovascular disorders
Read More
Japanese phase II trial for gaboxadol
Read More
Ambrisentan use in PAH patients who discontinue other ERA therapy
Read More